Other research, developed by García-Villalba et al. [31], also analyzing blood samples, corroborates the hypothesis about the activity of P2X7 in COVID-19 inflammation by finding an increased expression of soluble P2X7 receptors in the plasma of infected individuals when compared with the control group. The gene discussed is P2RX7; the disease is COVID-19.